Clinical Trial Update: A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 clinical trial of a CD19-targeted CAR T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia, currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19-targeted CAR-T cell therapy

Snippet

Sponsor: Autolus Limited | Conditions: Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING